1. Application of Machine Learning for Tumor Growth Inhibition – Overall Survival Modeling Platform. (13th December 2020) Authors: Chan, Phyllis; Zhou, Xiaofei; Wang, Nina; Liu, Qi; Bruno, René; Jin, Jin Y. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 1(2021) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Application of Machine Learning for Tumor Growth Inhibition – Overall Survival Modeling Platform. (13th December 2020) Authors: Chan, Phyllis; Zhou, Xiaofei; Wang, Nina; Liu, Qi; Bruno, René; Jin, Jin Y. Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 1(2021) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates. (24th July 2014) Authors: Wang, Xiaodong; Hruska, Matthew; Chan, Phyllis; Ahmad, Alaa; Freeman, Jeremy; Horga, Maria Arantxa; Hillson, Jan; Kansra, Vikram; Lopez‐Talavera, Juan‐Carlos Journal: Journal of clinical pharmacology Issue: Volume 55:Number 1(2015:Jan.) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 2: Exposure–response analyses for efficacy and safety variables. (24th July 2014) Authors: Hruska, Matthew; Wang, Xiaodong; Chan, Phyllis; Ahmad, Alaa; Freeman, Jeremy; Horga, Maria Arantxa; Hillson, Jan; Kansra, Vikram; Lopez‐Talavera, Juan‐Carlos Journal: Journal of clinical pharmacology Issue: Volume 55:Number 1(2015:Jan.) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six‐Minute Walk Test. (29th August 2017) Authors: Hamuro, Lora; Chan, Phyllis; Tirucherai, Giridhar; AbuTarif, Malaz Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 9(2017) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1). Issue 1 (25th August 2021) Authors: Wu, Benjamin; Sternheim, Nitzan; Agarwal, Priya; Suchomel, Julia; Vadhavkar, Shweta; Bruno, Rene; Ballinger, Marcus; Bernaards, Coen A.; Chan, Phyllis; Ruppel, Jane; Jin, Jin; Girish, Sandhya; Joshi, Amita; Quarmby, Valerie Journal: Clinical and translational science Issue: Volume 15:Issue 1(2022) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extension of the Alternative Intravenous Dosing Regimens of Atezolizumab into Combination Settings through Modeling and Simulation. (11th June 2022) Authors: Liu, Stephanie N.; Marchand, Mathilde; Liu, Xiaoyan; Ingle, Gladys; Maiya, Vidya; Graupner, Vilma; Elze, Markus C.; Chan, Phyllis; Hsu, Joy C.; Lin, Alyse; Vadhavkar, Shweta; Wu, Benjamin; Bruno, Rene Journal: Journal of clinical pharmacology Issue: Volume 62:Number 11(2022) Page Start: 1393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Model‐based Meta‐Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis. (7th September 2017) Authors: Chan, Phyllis; Bax, Leon; Chen, Chunlin; Zhang, Nancy; Huang, Shu‐Pang; Soares, Holly; Rosen, Glenn; AbuTarif, Malaz Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 10(2017) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pan‐cancer population pharmacokinetics and exposure‐safety and ‐efficacy analyses of atezolizumab in patients with high tumor mutational burden. Issue 6 (25th November 2020) Authors: Shemesh, Colby S.; Chan, Phyllis; Legrand, Fatema A.; Shames, David S.; Das Thakur, Meghna; Shi, Jane; Bailey, Lorna; Vadhavkar, Shweta; He, Xian; Zhang, Wei; Bruno, René Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 6(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework. (4th August 2021) Authors: Chan, Phyllis; Marchand, Mathilde; Yoshida, Kenta; Vadhavkar, Shweta; Wang, Nina; Lin, Alyse; Wu, Benjamin; Ballinger, Marcus; Sternheim, Nitzan; Jin, Jin Y.; Bruno, René Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 10(2021) Page Start: 1171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗